Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1398-1405

  Hemmeryckx, Bianca ^a   Van Wijk, Arnoud ^a   Reichert, Anja ^a   Kaartinen, Vesa ^a   De Jong, Ron ^a   Pattengale, Paul K ^a   Gonzalez Gomez, Ignacio ^a   Groffen, John ^a   Heisterkamp, Nora ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTIPORTER; BCR ABL PROTEIN; C3G PROTEIN; CRK LIKE PROTEIN; GENE PRODUCT; GUANOSINE TRIPHOSPHATASE; RAP PROTEIN; RAP1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; LEUKEMOGENESIS; LYMPHOMA; MACROPHAGE ACTIVATION; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; COS CELLS; FEMALE; FUSION PROTEINS, BCR-ABL; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA; MACROPHAGES, PERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PHENOTYPE; PROMOTER REGIONS (GENETICS);

EID: 0035866343     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Chronic myeloid leukemia
2. Molecular pathogenesis of chronic myeloid leukemia: Implications for new therapeutic strategy
3. A 41 kilodalton protein is a potential substrate for the 210 bcr/abl protein-tyrosine kinase in chronic myelogenous leukemia cells
4. Isolation chromosomal localization of CRKL, a human CRK-like gene
5. Cellular interactions of CRKL and SH2-SH3 adapter protein
6. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia
7. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia
8. Identification of CRKL as the constitutively phosphorylated 39-kDa-tyrosine phosphoprotein in chronic myelogenous leukemia ceels
9. Acute leukemia in BCR/ABL transgenic mice
10. Restricted oncogenicity of BCR/ABL P190 in transgenic mice
11. Tyrosine phosphorylation of murine crkl
12. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia
13. BCR/ABL induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl
14. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL transformed cells
15. Physiological signals and oncogenesis mediated through Crk family adapter proteins
16. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
17. The CRKL adapter protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene
18. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation
19. CRKL binding to BCR-ABL and BCR-ABL transformation
20. Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells
21. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients
22. Isolation of Not I sites from chromosome 22q11
23. The DNA sequence of human chromosome 22
24. The human BCR/ABL gene has a lethal effect on embryogenesis
25. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
26. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL P190 transgenic mice
27. Murine bone-marrow-derived macrophages
28. 2+-mediated activation of Rap1 in human platelets
29. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras
30. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances migration
31. Crkl activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G
32. C3G is tyrosinephosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells
33. Biochemical characterization of C3G: An exchange factor that discriminates between Rap1 and Rap2 and is not inhibited by Rap1A (S17N)
34. A role for Ras in v-Crk transformation
35. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site
36. Cas/Crk coupling serves as a "molecular switch" for induction of cell migration
37. Differential interaction of Crkl with Cbl or C3G, Hef-1, and γ subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (FcγRI)
38. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of Cbl and association with Crk adapter proteins
39. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G
40. C3G, a guanine nucleoticle-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of Crk and Grb2/Ash proteins
41. Integrin activation by R-Ras
42. An Eph receptor regulates integrin activity through R-Ras
43. Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein Crkl
44. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the BCR/ABL oncogene
45. Alternative signals to Ras for hematopoietic transformation by the BCR/ABL oncogene
46. Bcr/Abl oncoproteins bind directly to activators of the Ras signaling pathway
47. GCKR links the BCR/ABL oncogene and Ras to the stress-activated protein kinase pathway
48. The Bcr/Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
49. Hematopoiesis. How does it happen?
50. Unregulated proliferation of primitive chronic myelogenous leukemia progenitors in the presence of normal marrow adherent cells
51. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukemia
52. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV